Emergent Health Corp. Announces Release of New Health Product to be Offered Through a Recently Formed Marketing Division

KING OF PRUSSIA, Pa., March 29, 2011 (GLOBE NEWSWIRE) -- Emergent Health Corp. (Pink Sheets:EMGE) (the "Company") is pleased to announce it has formed a Division known as J.D.I. International Division (JDI™). JDI™ will bring to market what it considers a revolutionary new type of nutritional supplement. This unique and innovative product is a Vita-Stim Powered™ MultiVite/Multi Mineral. This one of its kind patented and patent pending product will provide the most commonly needed vitamins and minerals, plus promote stem cell nutrition. The JDI™ product is further enhanced with 1000 IU of Vitamin D, a nutrient suspected to be at deficiency levels in over 1 Billion people as reported by the World Health Organization.

The Company believes this product in the MultiVitamin-MultiMineral category is currently one of the most enhanced vitamin-mineral formulas on the market today. JDI™, a Network Marketing Division, is offering this key product at the best possible price and with the simplest and most ethical of marketing plans. The product is being offered to distributors with an initial goal of establishing Founders in the network. Details can be found at the JDI™ website http://jdimlm.com. Initial shipments of product have already been made.

Market Research has determined that multi vitamins and multi minerals are in the top 5 category of consumer demand. The Company believes that its JDI™ Daily Vitamin Mineral entry with the Vita-Stim Powered™ adjunct for stem cell nutrition support plus the added Vitamin D could open new markets for such a daily supplement.

Those interested in distributing any of our other products in the USA may also contact us below.

About Emergent Health Corp.

Emergent Health Corp., a diversified biotechnology firm, is focused on the health and wellness industry. With patented and patent pending nutritionally designed products, Emergent believes it is positioning itself as a leader in the field of Regenerative Medicine as defined by the National Institute of Health.

For Free Newsletter Updates Visit: http://emergenthealth.com

This press release contains certain "forward-looking" statements, defined in the United States Private Securities Litigation Reform Act of 1995, that involve a number of risks and uncertainties. Statements, which are not historical facts, are forward-looking statements. The company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are estimates reflecting the company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors that could cause actual results to differ materially from those estimated by the company.

This press release is provided for information purposes only and is not intended to constitute an offer to sell or a solicitation of an offer to buy securities.

CONTACT: Emergent Health Corp.
         Investor Relations
         866-427-6143
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here